Alzheimer’s Drug Market To Hit $13 Billion As FDA Approvals And Insurance Coverage Escalate8 Jun 2023—Forbes
The global market for Alzheimer’s disease treatments is expected to rise past $13 billion by 2030 as new drugs shown to slow cognitive decline are launched following key U.S. Food and Drug Administration approvals.
“The Alzheimer's disease (AD) market is projected to experience robust growth at a compound annual growth rate of 20% from $2.2 billion in 2020 to $13.7 billion in 2030 across the eight major markets,” GlobalData said in a new report Wednesday of the markets of the U.S., France,...
Alzheimer’s Drug Market To Hit $13 Billion As FDA Approvals And Insurance Coverage Escalate8 Jun 2023—ForbesThe global market for Alzheimer’s disease treatments is expected to rise past $13 billion by 2030 as new drugs shown to slow cognitive decline are launched following key U.S. Food and Drug Administration approvals. “The Alzheimer's disease (AD) market is projected to experience robust growth at a compound annual growth rate of 20% from $2.2 billion in 2020 to $13.7 billion in 2030 across the eight major markets,” GlobalData said in a new report Wednesday of the markets of the U.S., France,...